TrialFuture oncology (London, England)2026

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC.

Lillian L Siu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.